E. Almeida as Chief Executive Officer, effective immediately upon closing of the previously announced company acquisition.

The FDA has approved the NEXUS Aortic Arch Stent Graft enabling commercial launch of the NEXUS System in the US.

As organizations introduce additional technologies, including AI-enabled tools and CRM platforms, these gaps become more ...

Designed to expand treatment options for patients with cirrhosis and complications of portal hypertension, this ...

InVera Medical has received FDA 510 (k) clearance for the InVera Infusion Device, a new minimally invasive device designed to help physicians deliver treatment more effectively to diseased leg veins, ...

Allevion Medical Receives FDA Clearance for Vantage™, Introducing a Fully Disposable Approach to Minimally Invasive Spinal ...

New technology designed to provide a single irrigation management system for ureteroscopy, cystoscopy, percutaneous ...

The company's River stent will be available for adults with severe IIH – a debilitating, historically undertreated condition ...

New set of 73 Real World Evidence examples illustrate how RWD can support rigorous validation of novel device software ...

The acquisition expands Merit’s portfolio of therapeutic oncology products dedicated to the accurate diagnosis and localization of breast and soft tissue tumors.

In this part 2 of a 4-part series, Melissa highlight how the moment AI begins to influence decisions or workflows, it is ...